Literature DB >> 17670755

Echocardiographic and functional cardiopulmonary problems 6 months after first-time pulmonary embolism in previously healthy patients.

Brad G Stevinson1, Jackeline Hernandez-Nino, Geoffrey Rose, Jeffrey A Kline.   

Abstract

AIMS: We hypothesized that first-time submassive pulmonary embolism (PE) can cause persistent, significant cardiopulmonary problems, including right ventricular damage and worsened quality of life in patients with no prior cardiopulmonary disease. METHODS AND
RESULTS: We prospectively enrolled 205 patients without end-stage comorbidity diagnosed with submassive PE (systolic blood pressure always > 100 mmHg). Using explicit criteria, we identified a subgroup of 127 'previously healthy' patients who were free of cardiopulmonary disease or other disabling process. All patients had transthoracic echocardiography (echo) at the time of diagnosis. Six months later, survivors returned for repeat echo, 6 min walk distance (6MWD), and a quality-of-life survey. We defined a significant cardiopulmonary problem as either: (i) abnormal RV on echo (RV dilation or RV hypokinesis); or (ii) NYHA score > II or a 6MWD < 330 m at 6 months. Of 127 study patients, five had inadequate echos, nine were lost to follow-up, and four died, leaving 109 with complete data. Of 109 patients, 45 (41%) had cardiopulmonary problems 6 months after PE: 18 of 109 (17%) had only an abnormal RV, 18 of 109 (17%) had only functional limitation, and nine of 109 (8%) had both. Twenty-two patients (20%) indicated at least one index of poor quality-of-life: health status worse, not currently shopping, or perceived need for oxygen at home. Patients with cardiopulmonary problems demonstrated a significant decrease in SaO(2)% after 6MWD (97 +/- 1.3 pre-6MWD vs. 96 +/- 1.8% post-6MWD, P = 0.004 by paired t-test).
CONCLUSION: Six months after first-time PE, 41% of previously healthy patients had either an abnormal RV on echo, an NYHA score > II or a 6MWD < 330 m. Treatment studies of PE should include these persistent cardiopulmonary problems as study endpoints.

Entities:  

Mesh:

Year:  2007        PMID: 17670755     DOI: 10.1093/eurheartj/ehm295

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  26 in total

Review 1.  Pulmonary Embolism: The Astute Interventional Radiology Clinician.

Authors:  Akhilesh K Sista
Journal:  Semin Intervent Radiol       Date:  2017-03       Impact factor: 1.513

2.  Role of inflammation in right ventricular damage and repair following experimental pulmonary embolism in rats.

Authors:  John Albert Watts; Michael Aaron Gellar; Maria Obraztsova; Jeffrey Allen Kline; John Zagorski
Journal:  Int J Exp Pathol       Date:  2008-10       Impact factor: 1.925

3.  High Prevalence of Persistent Breathlessness Following Sub-Massive Pulmonary Embolism in Patients Presenting to a Large Regional Hospital in South Wales.

Authors:  Patrick Flood-Page
Journal:  Turk Thorac J       Date:  2020-11-01

Review 4.  How I use catheter-directed interventional therapy to treat patients with venous thromboembolism.

Authors:  Suresh Vedantham; Akhilesh K Sista
Journal:  Blood       Date:  2018-01-02       Impact factor: 22.113

5.  Contribution of fibrinolysis to the physical component summary of the SF-36 after acute submassive pulmonary embolism.

Authors:  Lauren K Stewart; Geoffrey W Peitz; Kristen E Nordenholz; D Mark Courtney; Christopher Kabrhel; Alan E Jones; Matthew T Rondina; Deborah B Diercks; James R Klinger; Jeffrey A Kline
Journal:  J Thromb Thrombolysis       Date:  2015-08       Impact factor: 2.300

Review 6.  Acute pulmonary embolism: endovascular therapy.

Authors:  Stephen P Reis; Ken Zhao; Noor Ahmad; Reginald S Widemon; Christopher W Root; Seth M Toomay; James M Horowitz; Akhilesh K Sista
Journal:  Cardiovasc Diagn Ther       Date:  2018-06

7.  Diagnostic evaluation and management of chronic thromboembolic pulmonary hypertension: a clinical practice guideline.

Authors:  Sanjay Mehta; Doug Helmersen; Steeve Provencher; Naushad Hirani; Fraser D Rubens; Marc De Perrot; Mark Blostein; Kim Boutet; George Chandy; Carole Dennie; John Granton; Paul Hernandez; Andrew M Hirsch; Karen Laframboise; Robert D Levy; Dale Lien; Simon Martel; Gerard Shoemaker; John Swiston; Justin Weinkauf
Journal:  Can Respir J       Date:  2010 Nov-Dec       Impact factor: 2.409

Review 8.  Rationale for catheter directed therapy in pulmonary embolism.

Authors:  Sailen G Naidu; Martha-Gracia Knuttinen; J Scott Kriegshauser; William G Eversman; Rahmi Oklu
Journal:  Cardiovasc Diagn Ther       Date:  2017-12

Review 9.  Can thrombus age guide thrombolytic therapy?

Authors:  Christopher Czaplicki; Hassan Albadawi; Sasan Partovi; Ripal T Gandhi; Keith Quencer; Amy R Deipolyi; Rahmi Oklu
Journal:  Cardiovasc Diagn Ther       Date:  2017-12

10.  Prospective evaluation of right ventricular function and functional status 6 months after acute submassive pulmonary embolism: frequency of persistent or subsequent elevation in estimated pulmonary artery pressure.

Authors:  Jeffrey A Kline; Michael T Steuerwald; Michael R Marchick; Jackeline Hernandez-Nino; Geoffrey A Rose
Journal:  Chest       Date:  2009-06-19       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.